MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cortical myoclonus (see myoclonus)"

  • 2025 International Congress

    Autosomal Dominant DHDDS-Related Movement Disorder Treated with Primidone

    D. Dewey, M. Khalaf, M. Hoerth, M. Osundiji, J. Caviness, S. Chiu (Scottsdale, USA)

    Objective: To describe novel clinical features and treatment response in a patient with neurodevelopmental disorder due to variants in dehydrodolichol diphosphate synthetase (DHDDS). Background: DHDDS…
  • 2025 International Congress

    The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

    S. Polet, L. Siegal, S. Fuchs, M. Tijssen, T. de Koning (Groningen, Netherlands)

    Objective: Mutations in the GOSR2 gene are associated with North Sea-Progressive Myoclonus Epilepsy (NS-PME). Because more recently additional phenotypes have been described we systematically reviewed…
  • 2025 International Congress

    Phenotypical Study of Progressive Myoclonic Epilepsy in Eastern Algeria

    SM. Behloul, Y. Mecheri, A. Boulefkhad (Constantine, Algeria)

    Objective: We aim to analyze phenotypical features of individuals from eastern Algeria having a PME phenotype followed in our center (Dr Benbadis University Hospital). Background:…
  • 2025 International Congress

    Interpretable Video Analysis for Movement Disorders, A Case Study of Essential Tremor vs. Cortical Myoclonus

    R. Martínez-García-Peña, L. Koens, M. Tijssen, G. Azzopardi (Groningen, Netherlands)

    Objective: To demonstrate the feasibility of data-driven models for discovering interpretable movement features relevant to Essential Tremor (ET) vs Cortical Myoclonus (CM) diagnosis using video.…
  • 2025 International Congress

    Beyond “benign”, tremor and epilepsy in FAME3-A New Family Report with Progressive Course and Cognitive Impairment

    D. Campo-Caballero, F. Magrinelli, M. Carazo, M. Maneiro, A. Vinagre-Aragón, E. Mondragón, A. Gabilondo, J. Ruiz-Martínez, L. Blázquez, H. Houlden, P. Iruzubieta (San Sebastian, Spain)

    Objective: To report a family with Familial Cortical Myoclonic Tremor with Epilepsy(FAME) type 3 diagnosed through long-read sequencing and presenting a progressive disease course and…
  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET

    J. Dalenberg, D. Peretti, L. Marapin, S. Jonker, E. Timmers, A. Vander Stouwe, M. Tijssen (Groningen, Netherlands)

    Objective: Understanding the differences in brain glucose metabolism between hyperkinetic movement disorders. Background: The Next Move in Movement Disorders (NEMO) study is a research initiative…
  • 2024 International Congress

    Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome

    H. Kaur, T. Goble, A. Fenoy, R. Ramdhani (Great neck, USA)

    Objective: To correlate local filed potential (LFP) spectral data with clinical improvement of the Unified Myoclonus Rating Scale (UMRS) in post-hypoxic myoclonus (PHM) syndrome treated…
  • 2024 International Congress

    Treatment of Post-hypoxic Myoclonus using Bilateral Subthalamic Nuclei Deep Brain Stimulation

    E. Tharp, J. Gavvala, M. Hafeez, S. Pati, S. Lhatoo, N. Tandon, R. Mehanna (Houston, USA)

    Objective: We report the first known case of a patient with refractory post-hypoxic myoclonus (PHM) and focal epilepsy implanted with bilateral subthalamic nuclei (STN) deep…
  • 2024 International Congress

    Cortical myoclonus in DHDDS: the multifaced presentation of a single movement disorder

    L. Pollini, M. Novelli, C. Greco, F. Pisani, V. Leuzzi, S. Galosi (Rome, Italy)

    Objective: To characterize the myoclonus spectrum and related clinical burden in patients with autosomal dominant DHDDS deficiency. Background: DHDDS deficiency is a neurometabolic disorder associated…
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley